November 22, 2016 - By Marguerite Chambers · 0 Comments
DS Healthcare Group Inc (NASDAQ:DSKX) institutional sentiment increased to 3 in 2016 Q2. Its up 1.00, from 2 in 2016Q1. The ratio has improved, as 4 institutional investors started new and increased holdings, while 2 sold and decreased positions in DS Healthcare Group Inc. The institutional investors in our partner’s database reported: 1.90 million shares, down from 1.91 million shares in 2016Q1. Also, the number of institutional investors holding DS Healthcare Group Inc in their top 10 holdings was flat from 0 to 0 for the same number . Sold All: 1 Reduced: 1 Increased: 2 New Position: 2.
DS Healthcare Group, Inc., doing business as DS Laboratories, is a personal care, product development and marketing company. The company has a market cap of $11.96 million. The Firm develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It currently has negative earnings. It develops technologies and products for hair care and personal care needs.
The stock increased 1.50% or $0.01 on November 21, hitting $0.67. It is down 0.00% since April 20, 2016 and is . It has underperformed by 4.56% the S&P500.
According to Zacks Investment Research, “DS Healthcare Group, Inc. is engaged in developing products for skin care, personal care, and hair care. It markets its products through a network of specialty retailers, spas, salons, and other distributors primarily in North America, Europe, Asia, and South America. DS Healthcare Group, Inc., formerly known as Divine Skin Inc., is headquartered in Miami Beach, Florida.”
Frigate Ventures Lp holds 0.11% of its portfolio in DS Healthcare Group Inc for 1.19 million shares. Bank Of America Corp De owns 504 shares or 0% of their US portfolio. Moreover, Barclays Plc has 0% invested in the company for 3 shares. The California-based Blackrock Fund Advisors has invested 0% in the stock. Blackrock Institutional Trust Company N.A., a California-based fund reported 140,008 shares.#img1#
Ratings analysis reveals 100% of DS Healthcare Group’s analysts are positive. Out of 2 Wall Street analysts rating DS Healthcare Group, 2 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $1.50 while the high is $6. The stock’s average target of $3.75 is 459.70% above today’s ($0.67) share price. DSKX was included in 3 notes of analysts from October 1, 2015. The firm has “Buy” rating given on Thursday, October 1 by H.C. Wainwright. Rodman & Renshaw maintained it with “Buy” rating and $1.50 target price in Thursday, March 31 report. Rodman & Renshaw initiated DS Healthcare Group Inc (NASDAQ:DSKX) rating on Friday, October 2. Rodman & Renshaw has “Buy” rating and $6 price target.
DS Healthcare Group, Inc., doing business as DS Laboratories, incorporated on January 26, 2007, is a personal care, product development and marketing company. The Firm develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It develops technologies and products for hair care and personal care needs. The Company’s technologies include Liposome Technology, which acts as a carrier agent, and is designed to enhance the act ion of the active ingredients in its products, and Nanosome Technology, which acts as a delivery vehicle, and is designed to infuse active compounds into targeted cells.
More notable recent DS Healthcare Group Inc (NASDAQ:DSKX) news were published by: Businesswire.com which released: “Robbins Arroyo LLP: DS Healthcare Group, Inc. (DSKX) Misled Shareholders …” on March 30, 2016, also Globenewswire.com with their article: “Ds Healthcare Group Comments on Recent Developments” published on March 29, 2016, Globenewswire.com published: “Lawsuit for Investors in DS Healthcare Group Inc (NASDAQ:DSKX) shares …” on April 20, 2016. More interesting news about DS Healthcare Group Inc (NASDAQ:DSKX) were released by: Globenewswire.com and their article: “DS Healthcare Enters Into Definitive Agreement â€‹to Acquire WR Group” published on August 17, 2015 as well as Businesswire.com‘s news article titled: “PhotoMedex to Sell Consumer and Professional Businesses to DS Healthcare Group” with publication date: February 22, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Marguerite Chambers